Kasuya; Yuji
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kasuya; Yuji.The latest application filed is for "method of treating cancer comprising administration of anti-her2 antibody-drug conjugate".
Company Profile
14.23.25
- Kasuya; Yuji - Tokyo JP
- Kasuya; Yuji - Sumida-ku JP
- Kasuya; Yuji - Tatebayashi-shi JP
- Kasuya; Yuji - Nagoya JP
- Kasuya; Yuji - Setagaya-ku JP
Patent Activity
| Patent | Date |
|---|---|
| Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate Grant 11,261,261 - Naito , et al. March 1, 2 | 2022-03-01 |
| (Anti-HER2 antibody)-drug conjugate Grant 11,185,594 - Naito , et al. November 30, 2 | 2021-11-30 |
| Complex containing oligonucleotide having immunopotentiating activity and use thereof Grant 11,015,202 - Ishii , et al. May 25, 2 | 2021-05-25 |
| Antibody-drug conjugate Grant 10,973,924 - Masuda , et al. April 13, 2 | 2021-04-13 |
| Method Of Treating Cancer Comprising Administration Of Anti-her2 Antibody-drug Conjugate App 20200385486 - NAITO; Hiroyuki ; et al. | 2020-12-10 |
| Sustained-release pharmaceutical composition for treatment and prevention of eye disease Grant 10,808,006 - Kasuya , et al. October 20, 2 | 2020-10-20 |
| Antibody-drug Conjugate App 20200282073 - MASUDA; Takeshi ; et al. | 2020-09-10 |
| Cationic lipid Grant 10,731,159 - Koizumi , et al. | 2020-08-04 |
| Antibody-drug conjugate produced by binding through linker having hydrophilic structure Grant 10,729,782 - Naito , et al. | 2020-08-04 |
| Cationic Lipid App 20200080086 - KOIZUMI; Makoto ; et al. | 2020-03-12 |
| Cationic lipid Grant 10,533,176 - Koizumi , et al. Ja | 2020-01-14 |
| Sustained-release Pharmaceutical Composition For Treatment And Prevention Of Eye Disease App 20190233466 - Kasuya; Yuji ; et al. | 2019-08-01 |
| Complex Containing Oligonucleotide Having Immunopotentiating Activity And Use Thereof App 20190112606 - ISHII; Ken ; et al. | 2019-04-18 |
| Anti-her2 Antibody-drug Conjugate App 20190077880 - NAITO; Hiroyuki ; et al. | 2019-03-14 |
| Sustained-release pharmaceutical composition for treatment and prevention of eye disease Grant 10,208,082 - Kasuya , et al. Feb | 2019-02-19 |
| Complex containing oligonucleotide having immunopotentiating activity and use thereof Grant 10,202,606 - Ishii , et al. Feb | 2019-02-12 |
| Antibody-drug conjugate Grant 10,195,288 - Masuda , et al. Fe | 2019-02-05 |
| Antibody-drug Conjugate App 20190008981 - Masuda; Takeshi ; et al. | 2019-01-10 |
| Anti-HER2 antibody-drug conjugate Grant 10,155,821 - Naito , et al. Dec | 2018-12-18 |
| Pharmaceutical Preparation For Delivery Of Porous Material To Large Intestine Or Lower Part Of Small Intestine App 20180311278 - Matsumoto; Koji ; et al. | 2018-11-01 |
| Wire harness Grant 10,000,167 - Kasuya , et al. June 19, 2 | 2018-06-19 |
| Antibody-drug Conjugate Produced By Binding Through Linker Having Hydrophilic Structure App 20180071403 - NAITO; Hiroyuki ; et al. | 2018-03-15 |
| Cationic Lipid App 20180051285 - KOIZUMI; Makoto ; et al. | 2018-02-22 |
| Antibody-drug conjugate produced by binding through linker having hydrophilic structure Grant 9,872,924 - Naito , et al. January 23, 2 | 2018-01-23 |
| Antibody-drug conjugate Grant 9,808,537 - Masuda , et al. November 7, 2 | 2017-11-07 |
| Cationic lipid Grant 9,803,199 - Koizumi , et al. October 31, 2 | 2017-10-31 |
| Sustained-release Pharmaceutical Composition For Treatment And Prevention Of Eye Disease App 20170260228 - Kasuya; Yuji ; et al. | 2017-09-14 |
| (anti-her2 Antibody)-drug Conjugate App 20170035906 - NAITO; Hiroyuki ; et al. | 2017-02-09 |
| Anti-her2 Antibody-drug Conjugate App 20160333112 - NAITO; Hiroyuki ; et al. | 2016-11-17 |
| Antibody-drug Conjugate App 20160279259 - Masuda; Takeshi ; et al. | 2016-09-29 |
| Novel Lipid App 20160257951 - KOIZUMI; Makoto ; et al. | 2016-09-08 |
| Complex Containing Oligonucleotide Having Immunopotentiating Activity And Use Thereof App 20160208260 - ISHII; Ken ; et al. | 2016-07-21 |
| Wire Harness App 20160107587 - KASUYA; Yuji ; et al. | 2016-04-21 |
| Spark plug with noble metal tip Grant 9,318,878 - Kasuya , et al. April 19, 2 | 2016-04-19 |
| Antibody-drug Conjugate Produced By Binding Through Linker Having Hydrophilic Structure App 20150352224 - NAITO; Hiroyuki ; et al. | 2015-12-10 |
| Antibody-drug Conjugate App 20150297748 - MASUDA; Takeshi ; et al. | 2015-10-22 |
| Spark plug Grant 8,841,826 - Kasuya , et al. September 23, 2 | 2014-09-23 |
| Spark plug and method of manufacturing the same Grant 8,810,116 - Kasuya , et al. August 19, 2 | 2014-08-19 |
| Spark Plug App 20140152170 - Kasuya; Yuji ; et al. | 2014-06-05 |
| Spark Plug App 20120313503 - Kasuya; Yuji ; et al. | 2012-12-13 |
| Spark Plug And Method Of Manufacturing The Same App 20120112619 - KASUYA; Yuji ; et al. | 2012-05-10 |
| Antibodies Modified With Hydrophobic Molecule App 20110269942 - Morita; Koji ; et al. | 2011-11-03 |
| Polymeric modifiers and pharmaceutical compositions Grant 7,811,556 - Kasuya , et al. October 12, 2 | 2010-10-12 |
| Polymeric modifiers and pharmaceutical compositions App 20060062754 - Kasuya; Yuji ; et al. | 2006-03-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 